These medications are generally prescribed for adults with a body mass index (BMI) of 30 kg/m or greater, or 27 kg/m or greater with at least one weight-related comorbidity such as type 2 diabetes or hypertension
It is a synthetic, engineered peptide derived from the transcription factor FOXO4
The hypoglycemic property of S
QUALITY IMPROVEMENT P2613 - ESOC25-1211 COMBINED GOVERNMENT AND ACADEMIC APPROACHES TO REDUCING HOSPITAL DISPARITIES IN KOREA: REGIONAL CARDIO-CEREBROVASCULAR DISEASE CENTRE AND STROKE CENTRE CERTIFICATION PROGRAMME Han-Yeong Jeong 1 , Seong-Eun Kim 2 , Eung-Joon Lee 3 , Jayoun Kim 3 , Nan Hee Park 3 , Joongyub Lee 4 , Ji Sung Lee 5 , Juneyoung Lee 6 , Jinju Park 7 , Jin-Hyuk Hong 7 , Hyun-Jae Kang 3 , Keun-Hwa Jung 3 , Hee-Joon Bae 2 1 SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul, South Korea, 2 Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea, 3 Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea, 4 Seoul National University College of Medicine, Seoul, South Korea, 5 Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea, 6 Korea University College of Medicine, Seoul, South Korea, 7 Korea Cardio-cerebrovascular Disease Management & Research Service, Seoul, South Korea Background and Aims: Disparities in stroke treatment and outcomes across hospitals have posed significant challenges in ensuring equitable healthcare outcomes
